Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Abcellera Biologics Inc
F:8QQ
Abcellera Biologics Inc
F:8QQ
Price:
11.46
EUR
4.56%
Market Closed
Market Cap:
€3.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Abcellera Biologics Inc
F:8QQ
|
CA |
|
C
|
CMX Gold & Silver Corp
F:6GS
|
CA |
|
E
|
East Africa Metals Inc
OTC:EFRMF
|
CA |
|
I
|
Ipsos SA
XMUN:IPZ
|
FR |
|
Paul Hartmann AG
F:PHH2
|
DE |
|
A
|
All In! Games SA
WSE:ALG
|
PL |
|
Avrupa Minerals Ltd
XTSX:AVU
|
CA |
|
Bactech Environmental Corp
OTC:BCCEF
|
CA |
|
Heads UP Ventures Limited
NSE:HEADSUP
|
IN |
|
RC Fornax PLC
F:8AD
|
UK |
|
H
|
Hapag Lloyd AG
OTC:HPGLY
|
DE |
|
Curtiss-Wright Corp
NYSE:CW
|
US |
|
W
|
Wellfield Technologies Inc
F:K8D
|
CA |
|
Y
|
Yura Tech Co Ltd
KOSDAQ:048430
|
KR |
|
Cannabis Global, Inc.
OTC:CBGL
|
US |
|
X
|
Xunlei Ltd
XMUN:4XN
|
CN |
|
B
|
Bristow Group Inc
F:ERG1
|
US |
|
E
|
Emperor Entertainment Hotel Ltd
XMUN:EM7A
|
HK |
|
FirstEnergy Corp
NYSE:FE
|
US |
|
S
|
Sofina SA
F:8FS
|
BE |
|
P
|
PT Temas Tbk
F:P5TA
|
ID |
|
D
|
Diversified Healthcare Trust
F:SNF
|
US |
|
E
|
Ekinops SA
F:E0J
|
FR |
|
U
|
Ultra Clean Holdings Inc
F:UCE
|
US |
Wall St Price Targets
8QQ Price Forecast
Based on 13 analysts
Based on 13 analysts
-55% Downside
from
€11.46
today
Abcellera Biologics Inc (8QQ)’s 12-month stock price forecast through October 2027 has a consensus target of €5.15, implying 55% downside. The forecast is based on price targets from 13 Wall Street analysts.
8QQ Analyst Rating
No ratings yet
No ratings yet
Abcellera Biologics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8QQ's stock price target?
Price Target
5.15
EUR
5.15
EUR
According to Wall Street analysts, the average 1-year price target for 8QQ is 5.15 EUR with a low forecast of 3.06 EUR and a high forecast of 10.61 EUR.
What is the Revenue forecast for Abcellera Biologics Inc?
Projected CAGR
33%
33%
Over the last 6 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 8 years is 33%.